Earnings Call Summary | Allogene Therapeutics(ALLO.US) Q3 2024 Earnings Conference

Futu NewsDec 30, 2024 19:54 · Conference Call

Oncology in Focus: How Emerging Therapies Are Reshaping Cancer Treatment

PR NewswireDec 27, 2024 00:26

3 Under-$10 Drug Stocks Wall Street Analysts Recommend Buying

Zacks Dec 24, 2024 20:00

THE POWER OF ALLO'S ALL-FIBER NETWORK COMING TO FLAGSTAFF, ARIZONA

PR NewswireDec 24, 2024 02:57

Allo Secures $100 Million in Debt Financing to Expand Bitcoin-Backed Lending Platform

PR NewswireDec 24, 2024 01:00

Allogene Therapeutics Acknowledges the Passing of Founding Board Member David Bonderman

GlobeNewswireDec 12, 2024 21:30